These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 26996750)

  • 1. Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients?
    Chen S; Lu X; Zhang W; Han Z; Yang W; Huang X; Jin X; Wang Z; Liang H; Qiu W; Cheng J; Shao B
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1366-70. PubMed ID: 26996750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preexisting dual antiplatelet treatment increases the risk of post-thrombolysis intracranial hemorrhage in Chinese stroke patients.
    Pan Y; Chen Q; Liao X; Zhao X; Wang C; Liu G; Liu L; Wang C; Wang D; Wang Y; Wang Y;
    Neurol Res; 2015 Jan; 37(1):64-8. PubMed ID: 24861494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion.
    Yeo LL; Kong WY; Paliwal P; Teoh HL; Seet RC; Soon D; Rathakrishnan R; Ong V; Lee TH; Wong HF; Chan BP; Leow WK; Yuan C; Ting E; Gopinathan A; Tan BY; Sharma VK
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2423-9. PubMed ID: 27344361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
    Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
    Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Thrombolysis and Passes of Thrombectomy as Predictors for Endovascular Revascularization in Ischemic Stroke.
    Angermaier A; Michel P; Khaw AV; Kirsch M; Kessler C; Langner S
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2488-95. PubMed ID: 27495833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of Intravenous Thrombolysis in Chronic Intracranial Hemorrhage: A Five-Year Multicenter Study.
    Zand R; Tsivgoulis G; Sadighi A; Singh M; McCormack M; Shahjouei S; Goyal N; Noorbakhsh-Sabet N; Alexandrov AW; Alexandrov AV
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):620-624. PubMed ID: 29100859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-to-White Blood Cell Ratio: A Prognostic Predictor for 90-Day Outcomes in Ischemic Stroke Patients with Intravenous Thrombolysis.
    Chen Z; Huang Y; Li S; Lin J; Liu W; Ding Z; Li X; Chen Y; Pang W; Yang D; Su Z; Li J; Weng Y; Zhang X
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2430-8. PubMed ID: 27372596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
    Nagaraja N; Tasneem N; Shaban A; Dandapat S; Ahmed U; Policeni B; Olalde H; Shim H; Samaniego EA; Pieper C; Ortega-Gutierrez S; Leira EC; Adams HP
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
    J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does renal dysfunction modify the effect of intravenous thrombolysis for acute ischemic stroke within 4.5 hours of onset? A multicenter observational study.
    Hsieh CY; Lin HJ; Sung SF; Yang YH; Lai EC; Hsieh HC; Chen CH
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):673-9. PubMed ID: 25577428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
    Chen J; Zhang Z; Chen L; Feng X; Hu W; Ge W; Li X; Jin P; Shao B
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2857-2862. PubMed ID: 30064868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.
    Bravo Y; Martí-Fàbregas J; Cocho D; Rodríguez-Yáñez M; Castellanos M; de la Ossa NP; Roquer J; Obach V; Maestre J; Martí-Vilalta JL
    Cerebrovasc Dis; 2008; 26(2):126-33. PubMed ID: 18560215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed Tomography Perfusion Derived Blood-Brain Barrier Permeability Does Not Yet Improve Prediction of Hemorrhagic Transformation.
    Horsch AD; Bennink E; van Seeters T; Kappelle LJ; van der Graaf Y; Mali WPTM; de Jong HWAM; Velthuis BK; Dankbaar JW;
    Cerebrovasc Dis; 2018; 45(1-2):26-32. PubMed ID: 29402765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
    Hsu PJ; Chen CH; Yeh SJ; Tsai LK; Tang SC; Jeng JS
    Cerebrovasc Dis; 2016; 42(1-2):117-21. PubMed ID: 27088493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Risk of Hemorrhagic Transformation After Thrombolysis for Acute Ischemic Stroke in Chinese Versus North Americans: A Comparative Study.
    Xu X; Wang D; Wang F; Norton C; Liu X; Selim M
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2381-2387. PubMed ID: 29778315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.